ArticleFrontiers in immunology2025

Comprehensive analysis of RFC4 as a potential biomarker for regulating the immune microenvironment and predicting immune therapy response in lung adenocarcinoma.

Jianqing Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.